21 patents currently held
13 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Sep 2027. from the record
Of the 13 now held by other companies, 8 name Albert Einstein College of Medicine as their current owner, and 5 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
5
Ending by 2030
Sep 2027
Next term end
15
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Dec 2032 · High confidence
Also notable
Ends Feb 2032 · High confidence
Also notable
Ends Sep 2027 · High confidence
Also notable
Ends Nov 2028 · High confidence
Also notable
Ends Sep 2029 · High confidence
Also notable
Ends Jan 2036 · High confidence
Also notable
Ends Feb 2040 · High confidence
Also notable
Ends Jul 2028 · High confidence
Delivery of Therapeutic Agents by a Collagen Binding Protein
US 9,579,273
Cited by 13 later US patents, top 25% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2032.
Cultures and protocols for diagnosis of toxigenic clostridium difficile
US 8,765,399
The largest patent family in this portfolio, 10 related applications, renewed at 3 of 3 maintenance windows. Protection runs to 2032.
Wheelchair Attachments
US 7,766,342
Renewed at every maintenance window since the 2010 grant; no more fees are due before its term ends in 2027.
System and Method for Monitoring Patient Care
US 7,734,477
Renewed at every maintenance window since the 2010 grant; no more fees are due before its term ends in 2028.
Hypoxic Conditioning in Patients with Exercise Limiting Conditions
US 8,475,340
Renewed at every maintenance window since the 2013 grant; no more fees are due before its term ends in 2029.
Transfemoral Transcaval Liver Access and Devices
US 11,504,100
Granted 2022. Computed term ends 2036.
Sterilizable Fiducial Beacon Strand for RF Target Tracking
US 11,612,716
Granted 2023. Computed term ends 2040.
Preparative Regimen for Engraftment, Growth and Differentiation of Non-Hematopoeitic Cells in Vivo After Transplantation
US 9,314,486
Granted 2016 and renewed at every maintenance window due so far. Protection runs to 2028.
Formerly held, still cited
Notable
Ends Sep 2036 · High confidence
The most cited patent in this portfolio, cited by 65 later US patents, top 5% of utility patents granted in 2020 in our data. Protection runs to 2036.
now held by Albert Einstein College of Medicine
Also notable
Ends Sep 2037 · High confidence
Cited by 19 later US patents, top 10% of utility patents granted in 2021 in our data. Protection runs to 2037.
now held by Albert Einstein College of Medicine
Also notable
Ends Jan 2033 · High confidence
Cited by 34 later US patents, top 25% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2033.
now held by Conversion Energy Enterprises Inc.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Apr 22, 2027The maintenance fee for Transfemoral Transcaval Liver Access and Devices (US 10,448,931) comes due Apr 22, 2027. Unpaid by Oct 22, 2027, it lapses early.
- 1 fee due Oct 19, 2027The maintenance fee for Preparative Regimen for Engraftment, Growth and Differentiation of Non-Hematopoeitic Cells in Vivo After Transplantation (US 9,314,486) comes due Oct 19, 2027. Unpaid by Apr 19, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
The largest of its 15 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,766,342 | Wheelchair Attachments held by Montefiore Medical Center and The University of Hartford In force · High confidence | In force | High confidence | |
| US 9,314,486 | Preparative Regimen for Engraftment, Growth and Differentiation of Non-Hematopoeitic Cells in Vivo After Transplantation In force · High confidence | In force | High confidence | |
| US 7,734,477 | System and Method for Monitoring Patient Care In force · High confidence | In force | High confidence | |
| US 8,475,340 | Hypoxic Conditioning in Patients with Exercise Limiting Conditions In force · High confidence | In force | High confidence | |
| US 8,845,654 | Scaled Head Frame Positioner and Tabletop Adapter In force · Medium confidence | In force | Medium confidence | |
| US 8,765,399 | Cultures and protocols for diagnosis of toxigenic clostridium difficile In force · High confidence | In force | High confidence | |
| US 9,579,273 | Delivery of Therapeutic Agents by a Collagen Binding Protein In force · High confidence | In force | High confidence | |
| US 11,001,820 | Delivery of Therapeutic Agents by a Collagen Binding Protein In force · High confidence | In force | High confidence | |
| US 11,992,195 | Transfemoral Transcaval Liver Access and Devices In force · Medium confidence | In force | Medium confidence | |
| US 11,504,100 | Transfemoral Transcaval Liver Access and Devices In force · High confidence | In force | High confidence |
Also on record, not counted in the 21: 13 patents in force now held by others · 6 patents ended · 9 applications pending · 16 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.